Why the study?
Does aspirin and cilostazol reduce angiographic restenosis compared to aspirin and clopidogrel in diabetic patients after drug-eluting stent implantation?
Population
280 diabetic patients who underwent successful drug-eluting stent implantation across 8 clinical sites.
Comparison
Aspirin and cilostazol after 1 month of initial… vs Aspirin and clopidogrel after 1 month of initial…
Design
RCT, randomized
Follow-up
mean 7.1 months
Authors
Loading...
Supports cilostazol-based DAPT in diabetics after DES; extends RCT evidence for restenosis reduction in this high-risk group.
Does aspirin and cilostazol reduce angiographic restenosis compared to aspirin and clopidogrel in diabetic patients after drug-eluting stent implantation?
In diabetic patients undergoing DES implantation, dual antiplatelet therapy with aspirin and cilostazol significantly reduced angiographic restenosis compared to aspirin and clopidogrel.
Ahn et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: